Healthcare provider profile · identity verified

Dan Mcdaniel, MD

Family Practice · RED BLUFF, CA · NPI 1861527459

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	674	97
Atorvastatin Calcium	Atorvastatin Calcium	408	126
Amlodipine Besylate	Amlodipine Besylate	325	104
Lisinopril	Lisinopril	304	93
Hydrochlorothiazide	Hydrochlorothiazide	300	90
Levothyroxine Sodium	Levothyroxine Sodium	296	90
Losartan Potassium	Losartan Potassium	249	74
Gabapentin	Gabapentin	235	57
Metoprolol Succinate	Metoprolol Succinate	204	63
Omeprazole	Omeprazole	182	50
Zolpidem Tartrate	Zolpidem Tartrate	175	34
Furosemide	Furosemide	174	51
Potassium Chloride	Potassium Chloride	171	45
Alprazolam	Alprazolam	167	27
Albuterol Sulfate Hfa	Albuterol Sulfate	162	54
Tamsulosin Hcl	Tamsulosin Hcl	136	41
Mounjaro	Tirzepatide	132	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	118	19
Morphine Sulfate Er	Morphine Sulfate	117	16
Tramadol Hcl	Tramadol Hcl	116	29
Ozempic	Semaglutide	115	17
Eliquis	Apixaban	105	22
Metformin Hcl	Metformin Hcl	104	32
Oxycodone Hcl	Oxycodone Hcl	104	16
Prednisone	Prednisone	102	55
Citalopram Hbr	Citalopram Hydrobromide	101	28
Pantoprazole Sodium	Pantoprazole Sodium	93	37
Clopidogrel	Clopidogrel Bisulfate	86	23
Azithromycin	Azithromycin	85	54
Diazepam	Diazepam	78	16
Lorazepam	Lorazepam	77	15
Baclofen	Baclofen	76	16
Clonazepam	Clonazepam	75	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	75	26
Pregabalin	Pregabalin	74	suppressed
Simvastatin	Simvastatin	74	25
Metoprolol Tartrate	Metoprolol Tartrate	69	19
Methadone Hcl	Methadone Hcl	68	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	67	suppressed
Trazodone Hcl	Trazodone Hcl	66	17
Escitalopram Oxalate	Escitalopram Oxalate	64	18
Triamcinolone Acetonide	Triamcinolone Acetonide	63	28
Allopurinol	Allopurinol	61	19
Carvedilol	Carvedilol	60	18
Sertraline Hcl	Sertraline Hcl	59	17
Estradiol	Estradiol	58	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	40
Fluticasone Propionate	Fluticasone Propionate	55	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	13
Xarelto	Rivaroxaban	55	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	15
Glimepiride	Glimepiride	54	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	14
Acyclovir	Acyclovir	51	suppressed
Aripiprazole	Aripiprazole	51	12
Famotidine	Famotidine	51	15
Montelukast Sodium	Montelukast Sodium	51	15
Ibuprofen	Ibuprofen	47	17
Fluconazole	Fluconazole	46	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	12
Ropinirole Hcl	Ropinirole Hcl	46	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	45	suppressed
Donepezil Hcl	Donepezil Hcl	43	12
Cephalexin	Cephalexin	42	13
Sumatriptan Succinate	Sumatriptan Succinate	42	suppressed
Spironolactone	Spironolactone	41	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	13
Synthroid	Levothyroxine Sodium	36	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	12
Ventolin Hfa	Albuterol Sulfate	36	16
Wixela Inhub	Fluticasone Propion/Salmeterol	36	12
Duloxetine Hcl	Duloxetine Hcl	35	12
Rizatriptan	Rizatriptan Benzoate	35	suppressed
Valacyclovir	Valacyclovir Hcl	35	15
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Meloxicam	Meloxicam	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	13
Paxlovid	Nirmatrelvir/Ritonavir	30	29
Jardiance	Empagliflozin	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	27	11
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Xtampza Er	Oxycodone Myristate	26	suppressed
Naproxen	Naproxen	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Levemir Flexpen	Insulin Detemir	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Terbinafine Hcl	Terbinafine Hcl	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Temazepam	Temazepam	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Atenolol	Atenolol	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Cefdinir	Cefdinir	13	suppressed
Digoxin	Digoxin	13	suppressed
Flavoxate Hcl	Flavoxate Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Topiramate	Topiramate	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Hydroxyurea	Hydroxyurea	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error